abstract |
The present invention relates to formulations of antiviral compounds, in particular [2- (6-amino-purin-9-iI) -1-methyl-e toximethyl] -phosphonic acid (tenofovir, PMPA), suitable for topical application, and its use in the reduction or prevention of acquisition and transmission of herpes simplex virus. |